Nexthera Capital’s Immune Design Corp. IMDZ Stock Holding History

Nexthera Capital’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-42,304	Closed	-$146K	–	61
2018 Q3	$146K	Buy	+42,304	New	+$159K	0.03%	55
2017 Q1	–	Sell	-198,600	Closed	-$1.09M	–	55
2016 Q4	$1.09M	Sell	198,600 -106,400	-35%	-$752K	0.64%	30
2016 Q3	$2.31M	Buy	305,000 +219,862	+258%	+$1.61M	1.42%	20
2016 Q2	$695K	Hold	85,138	–	–	0.6%	25
2016 Q1	$1.11M	Buy	85,138 +45,138	+113%	+$521K	1.15%	18
2015 Q4	$803K	Buy	+40,000	New	+$689K	1.14%	16

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nexthera Capital's IMDZ Position: Q4 2018 in Review

Nexthera Capital sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 42,304 shares — an estimated $146K sold.

Nexthera Capital first reported a position in IMDZ in Q4 2015 and held it in 6 quarters. The position peaked at $2.31M in Q3 2016. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

Nexthera Capital reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
Nexthera Capital sold 42,304 Immune Design Corp. shares in Q4 2018, an estimated $146K.
Nexthera Capital first reported a position in Immune Design Corp. in Q4 2015 and held it in 6 quarters.
Nexthera Capital's Immune Design Corp. position peaked at $2.31M in Q3 2016.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.